Publication | Open Access
Angiopep-2 Modified Exosomes Load Rifampicin with Potential for Treating Central Nervous System Tuberculosis
43
Citations
31
References
2023
Year
In summary, excellent targeting ability, high antitubercular activity and biocompatibility endow ANG-Exo-RIF with potential for use in future translation-aimed research and provide hope for an effective CNS-TB treatment.
| Year | Citations | |
|---|---|---|
Page 1
Page 1